Through these mechanisms, Smyca not only potentiates multiple cancer hallmarks induced by the two pathways, including metabolic reprogramming, migration, invasion, cancer stemness, metastasis and chemoresistance, but also evades TGF-β-induced growth inhibition by stimulating the c-Myc proliferating signal (Fig. 7G). Here, MIR23AHG is linked to cancer.